Interviews
August 13, 2018
Interview with Morgans Financial Limited
July 6, 2017
Interview with Morgans Financial Limited: Under the microscope
February 21, 2017
Interview with Finance News Network
July 26, 2016
Interview with Sky News Business
April 19, 2016
Interview with Morgans Senior Healthcare Analyst, Scott Power
April 6, 2016
TechKnow Invest 2016
March 21, 2016
Finance News Network
October 22, 2015
TechKnow Invest 2015
October 1, 2015
6PR 882 Radio, Perth, Western Australia
September 16, 2015
Morgans Healthcare Update
MEDIA INQUIRIES
Brian Leedman
VP, Corporate Affairs
+61 412 281 780
brian@resapphealth.com.au
ResApp Health Limited
ABN 51 094 468 318
Headquarters: Level 8, 127 Creek St, Brisbane, QLD 4000
Registered Office: Level 24, 44 St Georges Tce, Perth, WA 6000
CONTACT US
+61 8 6211 5099
+61 8 9218 8875
General Information
Clinical Studies
Investor Relations
LEGAL
Terms of Use
Privacy Policy
In the United States, ResAppDx is an investigational device and is not available for sale.
© 2019 ResApp Health Limited. All rights reserved. US Patent No. 10,098,569, Australian Patent No. 2013239327, Japanese Patent No. 6,435,257 and Patents Pending. ResApp Health®, the ResApp Health logo and ResAppDx® are registered trademarks of ResApp Health Limited in the United States and other countries.